Dudediligence.

HCW Biologics Inc

HCWBNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$426,423Sep ’24$394,804Dec ’24$5,065Mar ’25$6,550Jun ’25$15,606Sep ’25$27,010Dec ’25$6.5MMar ’26$121,730Jun ’26
Net income, by quarter
−$3.9MSep ’24−$3.4MDec ’24−$2.2MMar ’25−$1.9MJun ’25−$4.6MSep ’25$719,232Dec ’25$3.5MMar ’26−$5.2MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$0.00$6.7M$2.8M$2.6M$54,232
Gross profit$0.00$2.6M$560,360$959,403$10,846
Operating income−$13.4M−$15.1M−$25.7M−$29.5M−$13.2M
Net income−$12.9M−$14.9M−$25.0M−$30.0M−$8.0M
Operating cash flow−$11.0M−$10.4M−$22.5M−$14.2M−$13.4M
Free cash flow−$11.0M−$20.7M−$28.7M−$14.5M−$13.4M
Cash$11.7M$22.3M$3.6M$4.7M$2.0M
Debt$0.00$6.4M$6.3M$13.7M$6.8M
Shares outstanding35.8M36.0M36.0M1.1M3.3M